| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ImpediMed Limited (AU: IPD)
IPD Technical Analysis
5
| As on 22nd Dec 2025 IPD STOCK Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IPDSTOCK Price
| Open | 0.04 | Change | Price | % |
| High | 0.04 | 1 Day | -0.01 | -25.00 |
| Low | 0.03 | 1 Week | -0.01 | -25.00 |
| Close | 0.03 | 1 Month | -0.01 | -25.00 |
| Volume | 4219243 | 1 Year | -0.02 | -40.00 |
| 52 Week High 0.06 | 52 Week Low 0.03 | ||||
AU Australia Most Active Stocks
| AGE | 0.02 | 0.00% |
| EQR | 0.08 | 0.00% |
| LOT | 0.18 | -5.26% |
| LKE | 0.10 | 11.11% |
| SVL | 0.23 | 15.00% |
| MEI | 0.18 | 28.57% |
| VRC | 0.01 | % |
| CXO | 0.27 | 8.00% |
| MKR | 0.08 | 14.29% |
| PLS | 4.01 | 2.04% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| IPD Daily Charts |
IPD Intraday Charts |
Whats New @ Bazaartrend |
IPD Free Analysis |
|
|
IPD Important Levels Intraday
| RESISTANCE | 0.05 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| SUPPORT | 0.02 |
| SUPPORT | 0.02 |
| SUPPORT | 0.02 |
| SUPPORT | 0.01 |
IPD Forecast December 2025
| 4th UP Forecast | 0.05 |
| 3rd UP Forecast | 0.04 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.04 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | 0.01 |
IPD Weekly Forecast
| 4th UP Forecast | 0.05 |
| 3rd UP Forecast | 0.04 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.04 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | 0.01 |
IPD Forecast2025
| 4th UP Forecast | 0.09 |
| 3rd UP Forecast | 0.07 |
| 2nd UP Forecast | 0.06 |
| 1st UP Forecast | 0.05 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.03 |
ImpediMed Limited ( AU Australia Symbol : IPD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IPD Other Details
| Segment | EQ | |
| Market Capital | 269478016.00 | |
| Sector | Healthcare | |
| Industry | Medical Devices | |
| Offical website | > echo $website ; ?> | |
IPD Address
![]() |
||
IPD Latest News
IPD Business Profile
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was incorporated in 1999 and is headquartered in Pinkenba, Australia. Address: 50 Parker Court, Pinkenba, QLD, Australia, 4008
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

